Drug & Alcohol Test Kit Manufacturing in the US - Industry Market Research Report

Test phase: Shifting attitudes toward recreational drug use could negatively affect industry revenue moving forward

Drug and alcohol test kit manufacturers have benefited in recent years as demand for drug and alcohol test kits has risen. In recent years, growing rates of substance abuse and the penetration of fentanyl into the drug supply has made test kits more critical than ever. Manufacturers' growth was disrupted by the COVID-19 pandemic, as priorities abruptly shifted to combatting the pandemic. Several manufacturers, including industry leader Abbott, pivoted to develop and produce test strips that could detect the virus. Still, elevated rates of substance abuse post-COVID led manufacturers to recover revenue quickly, although global supply chain snags and labor shortages have been challenging to navigate, straining profit. In all, industry-wide revenue has been expanding at a CAGR of 3.2% over the past five years - totaling an estimated $3.7 billion in 2023 - when revenue will likely increase 1.0%.

This industry manufactures home diagnostic kits that test for the presence of alcohol or drugs in an individual. Test kits are intended for home use, although some may require a tester to send a sample to an authorized laboratory.

This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecasts, growth rates and an analysis of the industry's key players and their market shares.